Skin Health
John wasn’t sure he’d ever be able to ride a motorcycle again when his melanoma continued to progress despite aggressive treatments. One of his oncologists referred him to the Atlantic Melanoma Center, where Eric Whitman, MD was leading a phase II tumor infiltrating lymphocyte (TIL) clinical trial that he thought might help. This new type of personalized immunotherapy reversed the growth of John’s melanoma and has him thinking about resurrecting his bike from storage. Read more of his story >Skin Health Articles
Is Melanoma Suspected? Get 2nd Opinion From Specialist, Study Says
FRIDAY, Oct. 11, 2019 -- Melanoma is the most lethal type of skin cancer, and a new study finds that the diagnosis of a suspect lesion gains accuracy when a specialist pathologist is brought on board.
Many patients with melanoma are first diagnosed by general practitioners, dermatologists or plastic surgeons. A biopsy sample of the suspect lesion might then be sent to a general pathologist for further diagnosis, explained a team from the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA).
Many patients with melanoma are first diagnosed by general practitioners, dermatologists or plastic surgeons. A biopsy sample of the suspect lesion might then be sent to a general pathologist for further diagnosis, explained a team from the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA).
